ctrl K

AI Score

Unlock

Revelation Biosciences In... (REVB)

AI Score

Unlock

3.51

-0.03 (-0.85%)

At close: Feb 28, 2025, 3:59 PM

3.33

-5.14%

After-hours: Feb 28, 2025, 04:59 PM EST

Revelation Biosciences Income Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19
Revenue	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	25.05K	40.01K	69.17K	n/a	n/a
Gross Profit	-25.05K	-40.01K	-69.17K	n/a	n/a
Operating Income	-8.66M	-10.86M	-11.95M	-145.49K	-3.64K
Interest Income	n/a	n/a	n/a	10.91K	n/a
Pretax Income	-120.25K	-10.83M	-11.99M	-1.63M	-3.64K
Net Income	-120.25K	-10.79M	-11.99M	-1.63M	-3.64K
Selling & General & Admin	4.51M	5.49M	5.04M	145.49K	3.64K
Research & Development	4.15M	5.38M	6.91M	2.56M	n/a
Other Expenses	n/a	34.96K	-36.35K	n/a	n/a
Operating Expenses	8.66M	10.86M	11.95M	145.49K	3.64K
Interest Expense	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	144.26K	n/a
Cost & Expenses	8.66M	10.86M	11.95M	145.49K	3.64K
Income Tax	n/a	-34.96K	-219.78K	-3.8K	-171.86K
Shares Outstanding (Basic)	228K	17.97K	9.4K	8.66K	8.66K
Shares Outstanding (Diluted)	228.64K	17.97K	9.4K	8.66K	8.66K
EPS (Basic)	-0.53	-600.77	-1.28K	-188.18	-0.42
EPS (Diluted)	-0.53	-600.77	-1.28K	-188.18	-0.42
EBITDA	-95.21K	-10.84M	-11.93M	-145.49K	-3.64K
Depreciation & Amortization	25.05K	40.01K	69.17K	3.8M	171.86K